等离子体医学是医学技术的一个新兴分支。在传统治疗方法已经达到极限甚至存在弊端的情况下,冷大气等离子体(CAP)提供了突出的应用潜力。 等离子体医学是一个新创造的术语,代表着物理学、化学、生物科学和医学相结合的跨学科课题:KAP 与环境空气反应产生的活性氧和氮物种(RONS)在各种生物和细胞过程中发挥着关键作用。这使得 KAP 能够应用于医学领域。
Incap Corporation’s acquisition of Lacon Group has been completed
On 4 December 2025, Incap Corporation announced it had signed an
agreement to acquire 100% ownership of Lacon Group, a well-established
EMS company with facilities in Germany and Romania.
The acquisition was completed on 20 February 2026 after the approval of
applicable regulatory clearances in Germany and Romania. Lacon Group is
now a fully owned subsidiary of Incap Corporation, and its financial figures
will be consolidated into Incap Group’s reporting as of 20 February 2026.
The acquisition accelerates Incap’s growth strategy by strengthening its
position in defense, railway, and medical technology sectors, where Lacon
Group has reputable customers. Moreover, it marks an important strategic
step for Incap, as it expands the company’s offering into design and
development services, creating new opportunities to deliver greater value
across the product lifecycle.